Danaher (DHR) Stock Chart - Revenue & Earnings | Quarter Chart
Revenue by Product
Revenue by Geography
Revenue, Gross Profit, Operating and Net Income
Margin (%)
Operating Expenses
EBITDA
EPS
Revenue Variation (%)
Income Variation (%)
Revenue YoY Variation (%)
Income YoY Variation (%)
Price-to-Earning Ratio
Income Breakdown
Per Share Metrics
Expense Ratios
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt Ratio
Current Ratio
Quick Ratio
Cash & Equivalents
Total Assets
Total Liabilities
Shareholders Equity
Asset Composition
Debt Structure
Danaher (DHR) quarterly earnings & revenue
Danaher (DHR) reported revenue of $6.26B for Q2 2026, up 5.5% year-over-year, with net income of $870.00M and diluted EPS of $1.23.
Over the last four reported quarters, Danaher generated $25.11B in revenue and $4.00B in net income.
Danaher's next earnings report is scheduled for October 20, 2026 before market open; analysts estimate EPS of $1.93.
Danaher quarterly results
| Fiscal quarter | Revenue | Revenue YoY | Net income | EPS (diluted) |
|---|---|---|---|---|
| Q2 2026 | $6.26B | +5.5% | $870.00M | $1.23 |
| Q1 2026 | $5.95B | +3.7% | $1.03B | $1.45 |
| Q4 2025 | $6.84B | +4.6% | $1.20B | $1.68 |
| Q3 2025 | $6.05B | +4.4% | $908.00M | $1.27 |
| Q2 2025 | $5.94B | +3.4% | $555.00M | $0.77 |
| Q1 2025 | $5.74B | -0.9% | $954.00M | $1.32 |
| Q4 2024 | $6.54B | +2.1% | $1.09B | $1.49 |
| Q3 2024 | $5.80B | +3.1% | $818.00M | $1.12 |
Danaher (DHR) — frequently asked questions
When does Danaher (DHR) report earnings next?
Danaher is expected to report earnings on October 20, 2026 before market open. Analysts estimate EPS of $1.93.
What was DHR's revenue last quarter?
Danaher reported revenue of $6.26B in Q2 2026, up 5.5% from the same quarter a year earlier.
What was DHR's EPS last quarter?
Danaher reported diluted EPS of $1.23 in Q2 2026.
Is Danaher profitable?
Danaher is currently profitable, with $4.00B in net income over the last four reported quarters.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)